Pharmacovigilance – Products

This whitepaper discusses the classification of bsAbs targeting immunomodulatory checkpoints and highlights their applications in cancer immunotherapy.

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.

InSphero, takes a leading role in the recently awarded Chips JU European UNLOOC Project to advance its technology platform and address diversity in drug efficacy and safety testing.

InSphero announced its distribution partnership with Chayon. This partnership will bring InSphero’s reliable and scalable 3D in vitro solutions for drug development to South Korean researchers.

iPSC-derived organoid technology drives advances in drug discovery, disease modeling, and personalized medicine. Our cardiac, brain, intestinal, and liver organoids are essential for disease research and therapeutic development.

This application note explores the use of gas chromatography and mass spectrometry techniques to identify and quantify volatile compounds in rubber gasket extracts.

Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug development.

This whitepaper explores the emerging role of molecular genotyping in improving the accuracy of extended and rare blood type identification, reducing the risks of adverse reactions and supporting critical transfusion needs.

Top line data show that the randomized Phase II study of TG4001 in combination with avelumab versus avelumab in patients with recurrent or metastatic HPV16-positive cervical and anogenital tumors did not meet the primary objective of improvement.

APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s.